The development of antivirals mostly focuses on viro-centric approaches, but the need for small molecules capable of alleviating the functional perturbations of a tissue induced upon infection is lagging behind. This symptom-oriented complementary strategy used to suffer from the lack of appropriate...
ORGANISM(S): Orthobunyavirus Homo sapiens (Human)